In a landmark event that drew together the vanguard of Nigeria’s medical and pharmaceutical sectors, Reals Pharmaceutical Limited celebrated its 30th anniversary, signaling a significant milestone in the country’s healthcare landscape. The anniversary, themed "Three Decades of Excellence in Healthcare and Product Launch," served as both a retrospective of the company’s resilience and a forward-looking platform for the introduction of Dr Fizzo, a new therapeutic intervention designed to combat the rising incidence of acid-related gastrointestinal disorders. Held in Ikeja, the capital of Lagos State, the ceremony brought together industry regulators, healthcare professionals, traditional rulers, and business associates to reflect on three decades of pharmaceutical service.
Since its inception in the mid-1990s, Reals Pharmaceutical has navigated a complex economic environment characterized by fluctuating currency values, regulatory shifts, and infrastructure challenges. Despite these hurdles, the company has emerged as a cornerstone of the Nigerian pharmaceutical market, transitioning from a nascent distributor to a major player in the provision of high-quality, affordable medicines. The 30-year anniversary serves as a testament to the company’s ability to maintain a steady supply chain of essential medications during periods of both economic prosperity and scarcity.
A Legacy of Resilience and Faith
Addressing the distinguished guests, the Group Managing Director of Reals Pharmaceutical Limited, Pharm. Ade Popoola, provided a candid reflection on the company’s journey. He attributed the firm’s longevity to a combination of divine providence and the unwavering support of its stakeholders. Popoola noted that the path to thirty years was not without significant obstacles, citing the "ups and downs" inherent in the Nigerian business climate. He emphasized that the company’s ability to scale operations despite market storms was rooted in a commitment to integrity and the wellbeing of humanity.
"No doubt, it has not been a bed of roses," Popoola remarked. "We have witnessed boom and scarcity, but in all the storms, we have remained steadfast. Our goal remains the same as it was thirty years ago: to provide quality medicine that enhances the life of the average Nigerian."
This sentiment was echoed by the Chairman of Reals Pharmaceutical, Dr. Akinade Ogunbiyi, who described the company’s trajectory as a transformation from humble beginnings into a dominant industry force. Ogunbiyi reaffirmed the company’s dedication to its core values—integrity, innovation, passion, and customer focus. He assured the public that the next chapter of the company’s history would be defined by an even greater emphasis on innovation and the accessibility of healthcare solutions.
Addressing the Burden of Acid-Related Disorders
The highlight of the technical session was the keynote address delivered by Dr. Taiwo Alege, a Consultant Family Physician at the Lagos State University Teaching Hospital (LASUTH). Entitled "Acid-Related Disorders: The Way Forward," the presentation shed light on a growing public health concern in Nigeria. Dr. Alege highlighted the increasing prevalence of conditions such as dyspepsia, gastroesophageal reflux disease (GERD), gastritis, and peptic ulcer disease (PUD).
According to clinical data, acid-related disorders are among the most common reasons for outpatient visits in Nigerian hospitals. Dr. Alege warned that lifestyle choices are a primary driver of these conditions. The excessive consumption of alcohol, smoking, prolonged fasting, and high-stress levels common in urban centers like Lagos contribute significantly to gastric distress. Furthermore, she raised an alarm regarding the "indiscriminate use" of non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and aspirin, which can erode the stomach lining and lead to bleeding ulcers or perforations if left unchecked.
A critical point of the keynote was the warning against the long-term, unmonitored use of proton pump inhibitors (PPIs). While effective for short-term relief, Dr. Alege noted that many Nigerians self-medicate with these drugs for years without a formal medical review, potentially leading to complications such as nutrient malabsorption or increased risk of bone fractures.
The Introduction of Dr Fizzo
In response to these clinical challenges, Reals Pharmaceutical officially unveiled Dr Fizzo, a new product formulated to provide rapid relief for patients suffering from acid-related disorders. The product is positioned as a trusted, fast-acting solution for symptoms such as heartburn, bloating, and abdominal discomfort.
Prince Julius Adelusi-Adeluyi, a former Minister of Health and Chairman of the occasion, performed the official unveiling. He commended Reals Pharmaceutical for its proactive approach to product development, noting that Dr Fizzo addresses a specific gap in the market for effective and affordable gastrointestinal care. He described the success of Reals Pharmaceutical as a "testament to focus, humility, and grace," urging the management to remain steadfast as they take on the greater responsibilities that come with industry leadership.
The medical community has welcomed the addition of Dr Fizzo to the therapeutic arsenal. Experts suggest that when combined with lifestyle modifications—such as weight control, smoking cessation, and the avoidance of late-night meals—the new product could significantly improve the quality of life for millions of Nigerians suffering from chronic gastric issues.
Corporate Social Responsibility and Employee Empowerment
Beyond its commercial achievements, Reals Pharmaceutical utilized the anniversary to demonstrate its commitment to social impact and human capital development. The company launched the "Reals Small Scale Business Empowerment" initiative, a corporate social responsibility (CSR) program aimed at supporting the local economy in Ikeja.
During the event, six small business owners from the surrounding community were presented with grants of N150,000 each. These micro-grants are intended to provide working capital for local entrepreneurs, reflecting the company’s philosophy that corporate success should be shared with the immediate community.
The celebration also featured a rigorous employee recognition segment. In an industry where talent poaching is common, Reals Pharmaceutical showcased an impressive record of staff retention. Long-service awards, accompanied by cash rewards ranging from N250,000 to N2 million, were presented to employees who had served the company for a decade or more. A special recognition was reserved for Mr. Kunle Adesoye, who has been with Reals Pharmaceutical since its inception in 1994. His 30-year tenure was hailed as a symbol of the loyalty and stability that has defined the company’s corporate culture.
Industry Reactions and Broader Implications
The event saw attendance from high-ranking officials in the pharmaceutical sector, including the President of the Pharmaceutical Society of Nigeria (PSN), Pharm. Tanko Ayuba. In his remarks, Ayuba praised the company’s adherence to high standards and its contribution to the national drug supply chain. He urged Reals to maintain its trajectory of excellence, noting that the pharmaceutical industry is a critical pillar of national security.
The presence of traditional rulers, such as the Oloye of Oye-Ekiti, HRM Oba (Sir) Michael Oluwole Ademolaju, underscored the company’s deep roots in Nigerian society. The involvement of the clergy, represented by Pastor Samson Bamigbayan of the New Testament Assembly, added a spiritual dimension to the proceedings, emphasizing the importance of ethical foundations in business.
From a broader economic perspective, the 30-year milestone of Reals Pharmaceutical is indicative of the potential for indigenous firms to thrive in Nigeria’s healthcare sector. As the Federal Government continues to push for increased local manufacturing and a reduction in drug imports, companies like Reals are expected to play a pivotal role in achieving medicine security. The launch of Dr Fizzo is seen as a move toward diversifying the local product base, reducing reliance on expensive foreign alternatives for common ailments.
Looking Toward the Future
As Reals Pharmaceutical enters its fourth decade, the challenges of the pharmaceutical industry remain significant. Regulatory hurdles, the need for advanced cold-chain logistics for certain medications, and the persistent threat of counterfeit drugs require constant vigilance. However, the company’s leadership remains optimistic.
The anniversary celebration was not merely a look back at the past 30 years but a strategic positioning for the future. By investing in new product lines like Dr Fizzo and maintaining a robust CSR profile, Reals Pharmaceutical is cementing its status as a socially responsible corporate citizen.
The event concluded with a call to action for the healthcare sector to prioritize early diagnosis of acid-related disorders. With clinical investigations such as endoscopy becoming more accessible in urban centers like Lagos, medical professionals are hopeful that the combination of better diagnostics, lifestyle education, and innovative treatments like Dr Fizzo will lead to a reduction in the complications associated with gastric diseases.
As the curtains fell on the 30th-anniversary celebration, the message from Reals Pharmaceutical was clear: three decades of excellence is only the beginning. The company’s focus remains on the "wellbeing of humanity," a mission it intends to pursue with renewed vigor and a commitment to providing the quality medicines that Nigerians depend on.
